| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,979 | 10,940 | 9,740 | 13,493 | | Cost of Revenue | 10,273 | 8,004 | 7,434 | 11,256 | | | Gross Profit | 3,707 | 2,935 | 2,306 | 2,237 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,917 | 3,556 | 2,886 | 4,123 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 143 | 148 | 132 | 143 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 647 | (769) | (711) | (2,030) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 319 | 31 | 125 | (0) | | Earnings Before Interest And Taxes | 966 | (738) | (586) | (2,030) | | Interest Expense | 555 | 546 | 496 | 479 | | Income Before Tax | 411 | (1,284) | (1,082) | (2,509) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 411 | (1,284) | (1,082) | (2,509) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 411 | (1,284) | (1,082) | (2,509) | | Preferred Stock And Other Adjustments | (206) | (204) | (202) | (204) | | | Net Income Applicable To Common Shares | $205 | ($1,487) | ($1,283) | ($2,713) |
|
0.49% Nasdaq 0.00%
Income Statement
